RECENT ANALYSIS
Agency Estimates CMMI Increased Federal Spending by $5.4 Billion From 2011 through 2020; Agency Expected to Increase Spending by $1.3 Billion from 2021 to 2030
The Congressional Budget Office (CBO) released an updated estimate that indicates the Center for Medicare and Medicaid Innovation (CMMI), established under the Affordable Care Act (ACA) to explore innovative health care payment models, is expected to increase federal spending by $1.3 billion from 2021 to 2030. This follows a significant increase in spending by CMMI during its first decade, where… (Colocho, September 29, 2023) #Budget, #Costs, #Delivery Reform, #Program Integrity, #Public Health
Agency Releases New Medicaid Information and Questions for Public Comment on Mental Health Parity, Due December 4th
Today, the Centers for Medicare and Medicaid Services (CMS) released multiple pieces of information for states and stakeholders. The release, described in full below, includes a letter reinforcing the continuous eligibility requirement for individuals 19 and under; additional state data related to Medicaid and CHIP eligibility renewals, and questions for public comment on Medicaid and CHIP implementation of the Mental… (Marceno, September 29, 2023) #Coverage Decisions, #Mental and Behavioral Health, #Public Health
Proposed Rule Issued to Make Explicit that Lab Developed Tests (LDTs) Are Devices Under FDA Regulation; Comments Due Dec. 2
The Food and Drug Administration (FDA) issued a proposed rule to amend it regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Food, Drug, and Cosmetic (FD&C) Act, including when the manufacturer of the IVD is a laboratory (press release). What is it. Historically, the FDA has exercised enforcement discretion over laboratory developed tests (LDT),… (Slifer, September 29, 2023) #Food and Drug Administration, #Medical Devices